中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression

文献类型:期刊论文

作者Liu, Yuxiu1; Qing, Lihua2; Meng, Chuisong1; Shi, Jiajie2; Yang, Yan2; Wang, Ziwen1; Han, Guifang1; Wang, Yi2; Ding, Jian2; Meng, Ling-hua2
刊名JOURNAL OF MEDICINAL CHEMISTRY
出版日期2017-04-13
卷号60期号:7页码:2764-2779
ISSN号0022-2623
DOI10.1021/acs.jmedchem.6b01502
文献子类Article
英文摘要To discover new phenanthroindolizidine and phenanthroquinolizidine alkaloids as potential anticancer drug candidates, non-natural 6-O-desmethylcryptopleurine (2) and its derivatives were prepared. Most of the new compounds exhibited potent antiproliferative activity against A549 and BEL-7402 cells, with the lowest IC50 being 3 nM. Optically pure 2-R was further evaluated against a panel of 30 cancer cell lines and found to inhibit the proliferation of all tested cell lines, including three multidrug-resistant cell lines, with an average IC50 value of 2.1 nM, which is much lower than that of previously reported phenanthroindolizidine DCB-3503 (1, IC50: 166.7 nM). A mechanistic evaluation showed that 2-R potently inhibited cell growth and colony formation, which are associated with a delay in S phase progression through the inhibition of DNA synthesis. These results along with further study on the safety profile of these compounds will facilitate the discovery of new phenanthroindolizidine and phenanthroquinolizidine alkaloids for use as anticancer drug candidates.
WOS关键词PHENANTHROINDOLIZIDINE ALKALOIDS ; PHENANTHROQUINOLIZIDINE ALKALOIDS ; CELL-GROWTH ; CYNANCHUM-VINCETOXICUM ; CYTOTOXIC ACTIVITY ; PROTEIN-SYNTHESIS ; ANTITUMOR AGENTS ; CANCER-CELLS ; INHIBITION ; TYLOPHORINE
资助项目National Natural Science Foundation of China[21421062] ; National Natural Science Foundation of China[21372131] ; National Natural Science Foundation of China[21672117] ; National Natural Science Foundation of China[81321092] ; Specialized Research Fund for the Doctoral Program of Higher Education[20130031110017] ; Tianjin Natural Science Foundation[16JCZDJC32400]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000399436100011
出版者AMER CHEMICAL SOC
源URL[http://119.78.100.183/handle/2S10ELR8/272702]  
专题药理学第一研究室
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Meng, Ling-hua; Wang, Qingmin
作者单位1.Nankai Univ, Res Inst Elementoorgan Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China;
2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Liu, Yuxiu,Qing, Lihua,Meng, Chuisong,et al. 6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression[J]. JOURNAL OF MEDICINAL CHEMISTRY,2017,60(7):2764-2779.
APA Liu, Yuxiu.,Qing, Lihua.,Meng, Chuisong.,Shi, Jiajie.,Yang, Yan.,...&Wang, Qingmin.(2017).6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression.JOURNAL OF MEDICINAL CHEMISTRY,60(7),2764-2779.
MLA Liu, Yuxiu,et al."6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression".JOURNAL OF MEDICINAL CHEMISTRY 60.7(2017):2764-2779.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。